If your premature baby developed necrotizing enterocolitis — or you lost them to it — after being fed Similac or Enfamil in the NICU, you are probably asking three questions at once: how much, do I qualify, and is it too late? Here are the honest answers. Juries have already handed families more than $625 million in NEC verdicts, and the largest single award — $495 million — was just upheld on appeal. But there is still no settlement: no payout chart, no guaranteed check, and the federal cases have taken a hard road. The first federal trial is now only weeks away. Here is exactly where things stand in 2026.
Quick answer: There are no approved NEC baby formula settlements yet. State juries have returned individual verdicts ranging from $60 million to $495 million (the largest now affirmed on appeal), and financial analysts estimate the manufacturers’ total exposure at roughly $3 billion. Eligibility generally requires a premature infant fed cow’s-milk-based Similac or Enfamil who then developed NEC. The first federal bellwether trial — an Enfamil case — is scheduled for .
How Much Are NEC Settlements? (Estimated Payouts)
The most important thing to understand up front is this: there is no NEC formula settlement, and no per-child payout chart exists. Anyone who hands you a tidy “average NEC lawsuit payout” number is guessing. The only hard dollar figures in this litigation are individual jury verdicts from state-court trials, plus broad estimates that attorneys and analysts use to talk about value. The table below separates the two so you can see what is real and what is projection.
| Case or injury category | Reported amount or estimated range | Status / note |
|---|---|---|
| $60M verdict — Enfamil, infant death (Mar 2024) | $60 million | Individual Illinois state-court jury verdict against Mead Johnson |
| $495M verdict — Similac (Jul 2024) | $495 million ($95M compensatory + $400M punitive) | Missouri jury verdict against Abbott; upheld by a state appeals court in 2026 |
| $70M verdict — Similac, four families (Apr 2026) | $70 million ($53M compensatory + $17M punitive) | Individual Illinois state-court jury verdict against Abbott |
| Death / wrongful death (illustrative estimate) | ~$500,000 to $2 million+ | Speculative estimate only — no settlement exists; not an offer or guarantee |
| Severe NEC (surgery, lasting complications) | ~$250,000 to $1 million+ | Speculative estimate only — not an offer or guarantee |
| Moderate NEC | ~$75,000 to $250,000 | Speculative estimate only — not an offer or guarantee |
Read the lower three rows with real skepticism. Because no settlement has been reached, there is no “per person” or “per child” value, and there is no verified average. The jury verdicts above are genuine, but each reflects one family’s specific facts and severe outcomes — they are not what a typical claim is “worth,” and they can still face post-trial motions and further appeals. If you have followed how amounts work in other mass torts, the pattern here is similar to what you may have read on our Roundup lawsuit settlement amounts and AFFF lawsuit settlement amounts pages: verdicts make headlines, but most claimants are eventually resolved through negotiated tiers that only appear after a global settlement — which has not happened in the NEC litigation.
Quick Answers to the Top Questions
How much could I get?
No one can honestly promise a figure. There is no settlement and no payout matrix. State juries have awarded between $60 million and $495 million in individual cases, but those are outliers tied to specific, severe outcomes — not a guide to what an average claim receives. See the payouts section for the full picture.
Who qualifies?
Generally, a premature infant who was fed cow’s-milk-based Similac or Enfamil (often in the NICU) and then developed NEC, including cases that ended in death. You will need medical records. Full criteria are in the eligibility section.
Is there a settlement yet?
No. As of 2026 there is no approved global settlement in the federal litigation. The “settlement amounts” you see online are jury verdicts and estimates, not guaranteed payouts.
Which formulas?
Cow’s-milk-based Similac (Abbott) and Enfamil (Mead Johnson / Reckitt), including premature-infant formulas and human-milk fortifiers. Details in the formulas section.
What’s the deadline?
It depends entirely on your state, and minors’ claims are often paused (“tolled”) until the child grows up. There is no single national deadline — see the statute-of-limitations section and speak with an attorney promptly.
Who Qualifies for an NEC Lawsuit?
Eligibility in the NEC formula litigation is fairly specific. Lawsuits center on premature babies who were given a cow’s-milk-based formula or fortifier and then developed necrotizing enterocolitis. The four building blocks below are what attorneys look for first.
| Requirement | Detail |
|---|---|
| Prematurity | Baby born premature — typically before about 37 weeks. Many of the strongest cases involve infants born before 32 weeks or at very low birth weight (often under ~1,500 grams). |
| Cow’s-milk-based Similac or Enfamil | The infant was fed a bovine (cow’s-milk) formula or fortifier, frequently in the NICU. “How do I know if my baby was given cow-milk formula in the NICU?” — the answer is almost always in the hospital’s feeding orders and NICU records. |
| NEC diagnosis | A documented diagnosis of necrotizing enterocolitis, surgery for NEC, lasting complications, or a death attributed to NEC. |
| Records | NICU and medical records that connect the three points above: proof of prematurity, evidence the cow’s-milk product was fed, and the NEC diagnosis or cause of death. |
If a hospital’s feeding decisions are part of your story, your situation may also touch on birth-injury law. Our guide to birth injury attorneys and proving medical negligence explains how those overlapping claims can work alongside a product-liability case against the formula maker.
Which Formulas Are Involved? (Similac & Enfamil)
Yes — both Similac and Enfamil are named in the litigation. The cases target the two dominant makers of cow’s-milk-based preterm nutrition:
- Abbott — Similac. Including premature-infant products such as Similac Special Care and Abbott’s human-milk fortifiers.
- Mead Johnson / Reckitt — Enfamil. Including Enfamil Premature formula and related preterm products.
The common thread is that these are bovine (cow’s-milk)-based products fed to fragile preterm babies. The lawsuits do not claim the formula is contaminated or defective in the manufacturing sense; they are failure-to-warn claims, alleging the companies did not adequately warn families and doctors that cow’s-milk formula carries a higher NEC risk for premature infants than human milk. That distinction matters, and it sits at the heart of how these product liability claims are argued. Importantly, there has been no recall of these products — regulators continue to view preterm formula as a necessary option when human milk is not available.
The Science: Why Formula Is Linked to NEC
Necrotizing enterocolitis is a serious, sometimes fatal intestinal disease that strikes premature babies, causing portions of the bowel to become inflamed and die. It is one of the most dangerous conditions in the NICU.
The research consistently shows that human milk is protective and that formula-fed preemies develop NEC at higher rates. In a 2024 randomized clinical trial published in JAMA, NEC occurred in about 9% of extremely preterm infants fed preterm formula versus roughly 4% fed donor human milk — close to double the rate. Older randomized data and reviews have reported even larger gaps. This evidence base is what plaintiffs rely on.
But honesty requires the other half of the picture, because it is exactly what the manufacturers argue and what federal judges have weighed. In an October 2024 consensus statement, the FDA, CDC, and NIH concluded that prematurity is the primary risk factor for NEC, that human milk significantly reduces — but does not eliminate — the risk, and that there is no conclusive proof that preterm formula itself causes NEC. In other words, the science strongly links the absence of human milk to higher NEC risk, while stopping short of declaring formula a proven cause. That nuance is not a technicality; it is the central scientific battleground of these cases.
NEC Lawsuit Verdicts So Far (2024–2026)
Every NEC dollar figure that has actually been awarded came from a state court, not the federal litigation. Here is the honest scoreboard:
- $60 million (March 2024, Illinois). A jury found against Mead Johnson in an Enfamil case involving the death of a premature infant — the first major plaintiff win.
- $495 million (July 2024, Missouri). A jury awarded $95 million in compensatory and $400 million in punitive damages against Abbott over Similac. A state appeals court upheld the full verdict in 2026, rejecting Abbott’s key defenses.
- $70 million (April 2026, Illinois). A Cook County jury awarded four families a combined $53 million in compensatory damages and $17 million in punitive damages against Abbott over Similac.
That is more than $625 million in cumulative verdicts. The picture is not one-sided, though: in a separate 2024 trial the manufacturers actually won a defense verdict, which a Missouri court later set aside after finding misconduct by defense counsel, ordering a retrial.
The federal story is where the honesty really matters. In the federal multidistrict litigation, the first three bellwether (test) cases — all against Abbott/Similac — were dismissed on summary judgment before reaching a jury. Crucially, the judge did not throw out the plaintiffs’ scientific experts; she let their causation testimony stand. The cases were dismissed on a different, narrower ground: the court concluded those plaintiffs could not show a feasible safer alternative that could be mass-produced at scale, since human milk cannot be manufactured in the quantities the NICU population needs. That is a real, sobering setback — and it is the kind of litigation risk every NEC claimant should understand before filing.
Where the Litigation Stands: MDL 3026 & 2026 Trials
The federal cases are consolidated as MDL No. 3026, In re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation, before U.S. District Judge Rebecca Pallmeyer in the Northern District of Illinois. As of mid-2026 there are roughly 800 cases pending in the MDL, with hundreds more proceeding in state courts.
The defining feature of 2026 is the split between state and federal courts. State juries have repeatedly sided with families; the federal MDL, by contrast, dismissed its first three Similac bellwethers. Then the picture shifted. On , Judge Pallmeyer denied Mead Johnson’s motion for summary judgment in an Enfamil case, clearing the first federal bellwether to go to a jury. The key dates now:
- — the first federal trial, an Enfamil case against Mead Johnson involving an infant who died from NEC.
- — the next federal trial, a Similac case against Abbott involving a child left with permanent injuries.
- Late 2026 into 2027 — additional “second-wave” bellwether trials are expected.
There is still no global settlement. Financial analysts, including Bloomberg Intelligence, have estimated the manufacturers’ combined eventual exposure at roughly $3 billion — but that is an outside projection, not money on the table. For context on how a large pharmaceutical mass tort tends to move from verdicts toward resolution, our overview of Depo-Provera lawsuit settlements tracks a comparable arc.
How to File an NEC Claim
Filing an NEC case is mostly about evidence. The practical steps:
- Gather the records. You will need NICU and medical records that establish prematurity, show the cow’s-milk Similac or Enfamil product was fed, and document the NEC diagnosis (or cause of death). Yes — these records are essential, and obtaining them is usually the first thing an attorney helps with.
- Consult a licensed attorney. An experienced mass-tort or product-liability lawyer can assess whether your facts fit the litigation and where your case should be filed.
- Understand MDL vs. state court. Despite the name, this is not a class action — each family has an individual claim. Federal cases are coordinated in MDL 3026 for pretrial purposes, while many plaintiffs have chosen state courts, where the verdicts have come. (If you want to understand the difference, see our explainer on how to file a class action lawsuit — and how an MDL differs from one.)
NEC Lawsuit Deadline: Statute of Limitations by State
This is the question where a wrong answer can cost a family their case, so be careful with anything online — including this article — that implies a single nationwide deadline. There isn’t one. Deadlines are set by each state’s statute of limitations, and the rules for children and for wrongful death are different again.
| Item | What to know |
|---|---|
| General statute of limitations | Varies by state — commonly around two years from the injury or its discovery, but the range is wide. Do not rely on a single number. |
| Minors’ claims | In many states a child’s own claim is “tolled” (paused) until they reach the age of majority, which can extend the window significantly — but the rules differ by state and are not automatic. |
| Wrongful-death claims | A separate, often shorter deadline that typically runs from the date of death rather than the date of injury. |
| First federal bellwether trial (Enfamil / Mead Johnson). | |
| Second federal bellwether trial (Similac / Abbott). | |
| Late 2026 – early 2027 | Additional second-wave bellwether trials expected. |
Because tolling for minors and wrongful-death deadlines can pull in opposite directions, the only safe move is to have a licensed attorney check your specific state’s deadline as soon as possible. Waiting to “see how the trials go” can quietly run out a clock you didn’t know was ticking.
Wrongful-Death NEC Claims
For families who lost a baby to NEC, this is the hardest section, and we are sorry you are reading it. A wrongful-death claim is legally distinct from an injury claim. In general, the right to file belongs to a defined group of survivors — most often a parent or the estate’s representative — and the recoverable damages can include medical and funeral costs, loss of the child’s life, and the family’s grief and loss, depending on the state.
The most important practical point is the deadline: wrongful-death claims usually run from the date of death and can be shorter than the injury deadline, so they deserve prompt attention. Our guide to wrongful death attorneys in 2026 walks through who can file and how these claims are valued, and a birth injury attorney can help if a hospital’s feeding decisions are also part of what happened.
Frequently Asked Questions
- How much are NEC baby formula settlements?
- There are no settlements yet, so there is no settlement amount. The only awarded figures are individual jury verdicts of $60 million, $495 million, and $70 million — outliers tied to severe, specific cases, not a guide to an average payout.
- Who qualifies for an NEC lawsuit?
- Generally, a premature infant who was fed cow’s-milk-based Similac or Enfamil (often in the NICU) and then developed NEC, including cases that ended in the child’s death. Medical records establishing all three points are required.
- Is there an NEC settlement yet?
- No. As of 2026 there is no approved global settlement in the federal litigation, and no per-child payout chart exists.
- Are Similac and Enfamil both part of the lawsuit?
- Yes. Abbott’s Similac and Mead Johnson/Reckitt’s Enfamil — specifically their cow’s-milk-based preterm formulas and fortifiers — are both named.
- What records do I need to file?
- NICU and medical records showing the baby was premature, that the cow’s-milk product was fed, and the NEC diagnosis or cause of death. Yes, NICU records are central to these claims.
- What’s the average NEC lawsuit payout?
- There is no reliable average, because no settlement has been reached. Any “average payout” figure circulating online is speculation, not a verified number.
- Can I file if my baby died from NEC?
- Yes — these are wrongful-death claims, which a defined group of survivors can bring. The deadline is separate and often shorter, so act promptly and consult an attorney.
- What’s the deadline to file in my state?
- It varies by state. Minors’ claims are often paused until the child grows up, and wrongful-death deadlines differ. There is no universal deadline — have a licensed attorney confirm yours.
- Has any family won an NEC verdict?
- Yes. State juries have awarded $60 million (2024), $495 million (2024, upheld on appeal in 2026), and $70 million (2026). All came from state courts, not the federal litigation.
- Where does the litigation stand in 2026?
- About 800 cases are pending in federal MDL 3026 before Judge Pallmeyer, plus hundreds in state courts. The first federal trial is set for July 6, 2026, with a second on August 10, 2026. No global settlement exists yet.
This article is for informational and educational purposes only and is not legal or medical advice. There is no approved NEC formula settlement; jury verdicts are individual, may be appealed or reduced, and do not guarantee any payout. Federal bellwether cases have had mixed outcomes, and litigation results vary. Statutes of limitations differ by state. Consult a licensed attorney about your specific situation before taking action.
Sources
- FDA, CDC & NIH — Consensus statement on premature infants and necrotizing enterocolitis (Oct 2024)
- JAMA (2024) — Randomized trial: donor human milk vs. preterm formula in extremely preterm infants
- Pediatric Research — Legal, clinical, and scientific perspectives on formula use and NEC risk
- Legal Newsline — Judge denies Mead Johnson summary judgment, sets up federal NEC trial
- Business Wire — First federal Enfamil NEC bellwether trial scheduled for July 6, 2026
Last updated: — to be updated after the July and August 2026 federal trials and any settlement news.

Daniel Hayes is the founder and sole researcher at AdvoraHQ. He covers U.S. personal finance, insurance, and consumer law — working directly from IRS publications, federal and state statutes, court opinions, and SEC filings rather than secondary summaries. His focus is the gap between what readers think they know and what the source documents actually say. Daniel is not a licensed attorney, CPA, or financial advisor; his articles are educational and not personalized advice. Reach him at Daniel.Hayes@advorahq.com.



